Sequencer | Tenderlake

Sequencer

Contract Value:
EUR 919K - 919K
Notice Type:
Contract Notice
Published Date:
17 December 2025
Closing Date:
19 December 2025
Location(s):
DEE02 Halle (Saale), Kreisfreie Stadt (DE Germany/DEUTSCHLAND)
Description:
Provision of an integrated sequencer for Next-Generation Sequencing with a fully automated workflow, including leasing, purchase options, necessary consumables, and personnel training.

The subject of the tender is the provision of an integrated sequencer with a complete solution for Next-Generation Sequencing (NGS), which offers a fully automated, targeted NGS workflow - starting with quantified nucleic acid or a prepared NGS library up to analysis and result delivery within one working day. The implementation of a modern NGS-based diagnostics is essential for the treatment of cancer patients, as a variety of medications are already used in first-line therapy tailored to the mutation status.

Scope of services

• Conclusion of a leasing agreement with a purchase option after the award of contract - The lessee is granted a purchase option for the leased item. The purchase option can be exercised by the lessee at any time through a unilateral written declaration to the lessor.
• Lease of an integrated NGS sequencer including all necessary components
• Lease duration: 18 months
• Option to purchase the device after the lease period
• Provision of necessary consumables (reagents, kits, cartridges, etc.)
• Conclusion of a separate framework agreement for the supply of consumables
• Duration of the framework agreement: 48 months
• Delivery, installation, commissioning, and training of personnel


LOT-0000
HAL_UK_2025_10
Sequencer.
The subject of the tender is the provision of an integrated sequencer with a complete solution for Next-Generation Sequencing (NGS), which offers a fully automated, targeted NGS workflow - starting with quantified nucleic acid or a prepared NGS library up to analysis and result delivery within one working day. The implementation of a modern NGS-based diagnostics is essential for the treatment of cancer patients, as a variety of medications are already used in first-line therapy tailored to the mutation status.

Scope of services

• Conclusion of a leasing agreement with a purchase option after the award of contract - The lessee is granted a purchase option for the leased item. The purchase option can be exercised by the lessee at any time through a unilateral written declaration to the lessor.
• Lease of an integrated NGS sequencer including all necessary components
• Lease duration: 18 months
• Option to purchase the device after the lease period
• Provision of necessary consumables (reagents, kits, cartridges, etc.)
• Conclusion of a separate framework agreement for the supply of consumables
• Duration of the framework agreement: 48 months
• Delivery, installation, commissioning, and training of personnel

The Buyer:
Universitätsklinikum Halle (Saale) AöR
Additional information:
Link:
View Full Notice
Link:
Additional document: 816604-1
Link:
Download Full Notice as PDF
CPV Code(s):
38434540 - Biomedical equipment